PCM Encore LLC Buys New Holdings in HCA Healthcare, Inc. $HCA

PCM Encore LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,263 shares of the company’s stock, valued at approximately $492,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $5,069,974,000. State Street Corp boosted its stake in HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after buying an additional 76,039 shares in the last quarter. Capital World Investors raised its stake in HCA Healthcare by 0.8% during the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after acquiring an additional 40,086 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Finally, Norges Bank bought a new position in HCA Healthcare during the 4th quarter valued at about $1,262,513,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.2%

HCA stock opened at $406.33 on Friday. The business has a fifty day moving average of $396.32 and a 200-day moving average of $444.25. The company has a market cap of $87.97 billion, a P/E ratio of 13.60, a PEG ratio of 1.41 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned $6.84 earnings per share. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. JPMorgan Chase & Co. dropped their price objective on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a report on Thursday. Cantor Fitzgerald decreased their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 7th. UBS Group cut their price objective on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Morgan Stanley lowered their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research note on Monday, July 27th. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.